Cargando…

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes

PURPOSE: To evaluate the predictive factors of long-term visual outcomes in neovascular age-related macular degeneration (nAMD) treated with antivascular endothelial growth factor (anti-VEGF) agents. METHODS: Unicentric retrospective review of patients with nAMD treated with anti-VEGF agents. Visual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedrosa, Ana Catarina, Sousa, Tiago, Pinheiro-Costa, João, Beato, João, Falcão, Manuel S., Falcão-Reis, Fernando, Carneiro, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471580/ https://www.ncbi.nlm.nih.gov/pubmed/28656102 http://dx.doi.org/10.1155/2017/4263017

Ejemplares similares

Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes
por: Pedrosa, Ana Catarina, et al.
Publicado: (2016)

Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
por: Neves Cardoso, Pedro, et al.
Publicado: (2017)

Choroidal and macular thickness changes induced by cataract surgery
por: Falcão, Manuel S, et al.
Publicado: (2014)

Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
por: Torres-Costa, Sónia, et al.
Publicado: (2022)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Kaiser, Stephanie M, et al.
Publicado: (2021)

Inflammatory Choroidal Neovascular Membranes: Clinical Profile, Treatment Effectiveness, and Visual Prognosis
por: Carrola, Gonçalo, et al.
Publicado: (2021)

Intraocular Pressure and Anterior Segment Morphometry Changes after Uneventful Phacoemulsification in Type 2 Diabetic and Nondiabetic Patients
por: Beato, João N., et al.
Publicado: (2019)

Structural and Biomechanical Corneal Differences between Type 2 Diabetic and Nondiabetic Patients
por: Beato, João N., et al.
Publicado: (2019)

Evaluation of Corneal Structure and Endothelial Morphological Characteristics in Type 2 Diabetic and Non-Diabetic Patients
por: Beato, João N, et al.
Publicado: (2020)

Transepithelial accelerated versus conventional corneal collagen crosslinking in patients with keratoconus: a comparative study
por: Madeira, Carolina, et al.
Publicado: (2019)

Two-Step Iridocorneal Endothelial Syndrome Management: Endocapsular Intraocular Lens and Artificial Iris Followed by Descemet’s Stripping Automated Endothelial Keratoplasty
por: Pinheiro-Costa, João, et al.
Publicado: (2023)

Increased Choroidal Thickness in Keratoconus Patients: Perspectives in the Disease Pathophysiology
por: Pinheiro-Costa, João, et al.
Publicado: (2019)

Cyclodialysis Cleft Treatment Using a Minimally Invasive Technique
por: Pinheiro-Costa, João, et al.
Publicado: (2015)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy, Balaji, et al.
Publicado: (2020)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022)

A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
por: Gemenetzi, Maria, et al.
Publicado: (2017)

Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
por: Pfau, Maximilian, et al.
Publicado: (2021)

Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
por: Wykoff, Charles C., et al.
Publicado: (2018)

Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
por: Kabanarou, Stamatina A, et al.
Publicado: (2017)

Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments
por: Hussain, Rehan M., et al.
Publicado: (2021)

Anti-VEGF Agents for the Treatment of Pigment Epithelial Detachments Associated with Neovascular Age-related Macular Degeneration: An Evidence-based Approach
por: Panos, Georgios D., et al.
Publicado: (2015)

Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration
por: Sobolewska, Bianka, et al.
Publicado: (2021)

Increased choroidal thickness is not a disease progression marker in keratoconus
por: Pinheiro-Costa, João, et al.
Publicado: (2020)

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
por: Yang, Shiqi, et al.
Publicado: (2016)

Genetic Association Analysis of Anti-VEGF Treatment Response in Neovascular Age-Related Macular Degeneration
por: Strunz, Tobias, et al.
Publicado: (2022)

A 10-Year Retrospective Clinical Analysis of Fungal Keratitis in a Portuguese Tertiary Centre
por: Cunha, Ana Maria, et al.
Publicado: (2020)

Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
por: Adrean, Sean D., et al.
Publicado: (2022)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study
por: Korva-Gurung, Ida, et al.
Publicado: (2023)

New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2012)

Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration
por: Arai, Yusuke, et al.
Publicado: (2020)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
por: Han, Fangyuan, et al.
Publicado: (2022)

Melatonin Inhibits VEGF-Induced Endothelial Progenitor Cell Angiogenesis in Neovascular Age-Related Macular Degeneration
por: Lin, Liang-Wei, et al.
Publicado: (2023)

Quantitative Optical Coherence Tomography Angiography Biomarkers in a Treat-and-Extend Dosing Regimen in Neovascular Age-Related Macular Degeneration
por: Cabral, Diogo, et al.
Publicado: (2020)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
por: Hirata, Akira, et al.
Publicado: (2017)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
por: Zampros, Ilias, et al.
Publicado: (2012)

Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies
por: Magalhães, Augusto, et al.
Publicado: (2021)

The Role of Atopy in the Choroidal Profile of Keratoconus Patients
por: Moleiro, Ana Filipa, et al.
Publicado: (2021)

Transepithelial Accelerated Corneal Collagen Cross-Linking: Two-Year Results
por: Cunha, Ana Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cick0s42e1fghrrktsuolmeo06